Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
academic, addressed, AE, ahead, ATM, Attn, Benza, Beta, CHEST, Chinese, cliff, condensed, Diego, disclaimer, Email, embedded, emotional, exacerbation, Fava, headquartered, ideation, impulsivity, Inline, interval, Kevin, learning, lifespan, Maher, multicenter, neurodevelopmental, occupational, onboard, overallotment, pattern, pervasive, prepaid, QT, reevaluated, remeasurement, retroactive, retroactively, RL, San, SB, sixty, slowly, Strek, Tang, Topline, underrepresented, VA, Wainwright
Removed:
analyst, attending, Florida, inclusion, insufficient, Nayar, redeemable, supplement, threshold
Filing tables
Filing exhibits
RVPH similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (File No. 333-254551) and the Registration Statement on Form S-3 (No. 333- 262348), of Reviva Pharmaceuticals Holdings, Inc. of our report dated March 15, 2022 relating to the consolidated financial statements which appears in this Form 10-K for the year ended December 31, 2021.
/s/ArmaninoLLP San Ramon, California |
March 15, 2022